Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 896

1.

Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome.

Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, Sauren B, Mohr FW, Walther T, Zickmann B, Iversen S, Felderhoff T, Cartier R, Bonan R.

J Am Coll Cardiol. 2007 Jul 3;50(1):69-76.

2.

Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving system.

Grube E, Buellesfeld L, Mueller R, Sauren B, Zickmann B, Nair D, Beucher H, Felderhoff T, Iversen S, Gerckens U.

Circ Cardiovasc Interv. 2008 Dec;1(3):167-75. doi: 10.1161/CIRCINTERVENTIONS.108.819839.

3.

Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study.

Grube E, Laborde JC, Gerckens U, Felderhoff T, Sauren B, Buellesfeld L, Mueller R, Menichelli M, Schmidt T, Zickmann B, Iversen S, Stone GW.

Circulation. 2006 Oct 10;114(15):1616-24.

4.

Retrograde transarterial implantation of a nonmetallic aortic valve prosthesis in high-surgical-risk patients with severe aortic stenosis: a first-in-man feasibility and safety study.

Schofer J, Schlüter M, Treede H, Franzen OW, Tübler T, Pascotto A, Low RI, Bolling SF, Meinertz T, Reichenspurner H.

Circ Cardiovasc Interv. 2008 Oct;1(2):126-33. doi: 10.1161/CIRCINTERVENTIONS.108.800607.

5.

Surgical aspects of endovascular retrograde implantation of the aortic CoreValve bioprosthesis in high-risk older patients with severe symptomatic aortic stenosis.

Marcheix B, Lamarche Y, Berry C, Asgar A, Laborde JC, Basmadjian A, Ducharme A, Denault A, Bonan R, Cartier R.

J Thorac Cardiovasc Surg. 2007 Nov;134(5):1150-6.

6.

Transcatheter aortic valve implantation in the operating room: early experience.

Fusari M, Alamanni F, Bona V, Muratori M, Salvi L, Parolari A, Biglioli P.

J Cardiovasc Med (Hagerstown). 2009 May;10(5):383-93.

PMID:
19449470
7.

Clinical experience with the second-generation 3f Enable sutureless aortic valve prosthesis.

Aymard T, Kadner A, Walpoth N, Göber V, Englberger L, Stalder M, Eckstein F, Zobrist C, Carrel T.

J Thorac Cardiovasc Surg. 2010 Aug;140(2):313-6. doi: 10.1016/j.jtcvs.2009.10.041.

8.

Six-month results of a repositionable and retrievable pericardial valve for transcatheter aortic valve replacement: the Direct Flow Medical aortic valve.

Treede H, Tübler T, Reichenspurner H, Grube E, Pascotto A, Franzen O, Mueller R, Low R, Bolling SF, Meinertz T, Schofer J.

J Thorac Cardiovasc Surg. 2010 Oct;140(4):897-903. doi: 10.1016/j.jtcvs.2010.01.017.

9.

Feasibility and initial results of percutaneous aortic valve implantation including selection of the transfemoral or transapical approach in patients with severe aortic stenosis.

Rodés-Cabau J, Dumont E, De LaRochellière R, Doyle D, Lemieux J, Bergeron S, Clavel MA, Villeneuve J, Raby K, Bertrand OF, Pibarot P.

Am J Cardiol. 2008 Nov 1;102(9):1240-6. doi: 10.1016/j.amjcard.2008.06.061.

PMID:
18940300
10.

Transcatheter aortic valve implantation for severe aortic stenosis-a new paradigm for multidisciplinary intervention: a prospective cohort study.

Dworakowski R, MacCarthy PA, Monaghan M, Redwood S, El-Gamel A, Young C, Bapat V, Hancock J, Wilson K, Brickham B, Wendler O, Thomas MR.

Am Heart J. 2010 Aug;160(2):237-43. doi: 10.1016/j.ahj.2010.05.014.

PMID:
20691827
11.

Performance of valve-in-valve for severe para-prosthetic leaks due to inadequate transcatheter aortic valve implantation.

Napodano M, Gasparetto V, Tarantini G, Fraccaro C, Yzeiraj E, Gerosa G, Isabella G, Iliceto S.

Catheter Cardiovasc Interv. 2011 Dec 1;78(7):996-1003. doi: 10.1002/ccd.23181.

PMID:
22114036
12.

Transcatheter aortic valve implantation in patients with severe symptomatic aortic valve stenosis-predictors of mortality and poor treatment response.

Gotzmann M, Pljakic A, Bojara W, Lindstaedt M, Ewers A, Germing A, Mügge A.

Am Heart J. 2011 Aug;162(2):238-245.e1. doi: 10.1016/j.ahj.2011.05.011.

PMID:
21835283
13.

High-risk aortic valve replacement: are the outcomes as bad as predicted?

Grossi EA, Schwartz CF, Yu PJ, Jorde UP, Crooke GA, Grau JB, Ribakove GH, Baumann FG, Ursumanno P, Culliford AT, Colvin SB, Galloway AC.

Ann Thorac Surg. 2008 Jan;85(1):102-6; discussion 107.

PMID:
18154791
14.

Novel therapeutic aspects of percutaneous aortic valve replacement with the 21F CoreValve Revalving System.

Berry C, Asgar A, Lamarche Y, Marcheix B, Couture P, Basmadjian A, Ducharme A, Laborde JC, Cartier R, Bonan R.

Catheter Cardiovasc Interv. 2007 Oct 1;70(4):610-6.

PMID:
17894307
15.

Suitability of stentless bioprostheses for combined replacement of the aortic valve and ascending aorta.

Auriemma S, Bortolotti U, Piccin C, Brunelli M, Magagna P, Lamascese N, Paccanaro M, Fabbri A.

Ital Heart J. 2004 Sep;5(9):673-7.

PMID:
15568595
16.

Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis.

Ussia GP, Barbanti M, Petronio AS, Tarantini G, Ettori F, Colombo A, Violini R, Ramondo A, Santoro G, Klugmann S, Bedogni F, Maisano F, Marzocchi A, Poli A, De Carlo M, Napodano M, Fiorina C, De Marco F, Antoniucci D, de Cillis E, Capodanno D, Tamburino C; CoreValve Italian Registry Investigators..

Eur Heart J. 2012 Apr;33(8):969-76. doi: 10.1093/eurheartj/ehr491.

17.

[Experience and learning curve with transapical aortic valve implantation].

Wendt D, Eggebrecht H, Kahlert P, Heine T, Kottenberg E, Massoudy P, Kamler M, Peters J, Erbel R, Jakob H, Thielmann M.

Herz. 2009 Aug;34(5):388-97. doi: 10.1007/s00059-009-3265-y. German.

PMID:
19711035
18.

Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry.

Bosmans JM, Kefer J, De Bruyne B, Herijgers P, Dubois C, Legrand V, Verheye S, Rodrigus I; Belgian TAVI Registry Participants..

Interact Cardiovasc Thorac Surg. 2011 May;12(5):762-7. doi: 10.1510/icvts.2010.253773.

19.

Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery.

Popma JJ, Adams DH, Reardon MJ, Yakubov SJ, Kleiman NS, Heimansohn D, Hermiller J Jr, Hughes GC, Harrison JK, Coselli J, Diez J, Kafi A, Schreiber T, Gleason TG, Conte J, Buchbinder M, Deeb GM, Carabello B, Serruys PW, Chenoweth S, Oh JK; CoreValve United States Clinical Investigators..

J Am Coll Cardiol. 2014 May 20;63(19):1972-81. doi: 10.1016/j.jacc.2014.02.556.

20.

Thirty-day outcome and vascular complications after transarterial aortic valve implantation using both Edwards Sapien and Medtronic CoreValve bioprostheses in a mixed population.

Tchetche D, Dumonteil N, Sauguet A, Descoutures F, Luz A, Garcia O, Soula P, Gabiache Y, Fournial G, Marcheix B, Carrie D, Fajadet J.

EuroIntervention. 2010 Jan;5(6):659-65.

PMID:
20142215
Items per page

Supplemental Content

Support Center